TrialStem cell research & therapy2026

Intracerebroventricular human mesenchymal stem cells induce MMP9-driven transient inflammation in Alzheimer's disease.

Su Hyeon Myeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.